An Analysis of the Changes in the Sarcoma Tumor Immune Microenvironment Following Trabectedin
Latest Information Update: 23 Feb 2024
At a glance
- Drugs Trabectedin (Primary)
- Indications Liposarcoma; Sarcoma
- Focus Pharmacodynamics
- 13 Oct 2023 According to Janssen Pharmaceuticals media release, Janssen Pharmaceuticals has changed its name to Johnson & Johnson Innovative Medicine
- 06 Sep 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 20 Jun 2019 Status changed from suspended to recruiting.